Clinical Trials Logo

T-cell Lymphoma Adults clinical trials

View clinical trials related to T-cell Lymphoma Adults.

Filter by:
  • None
  • Page 1

NCT ID: NCT06149390 Completed - Clinical trials for T-cell Lymphoma Adults

ASCT Versus Chemotherapy as First-Line Consolidation Therapy inT-Cell Lymphoma

Start date: January 1, 2014
Phase:
Study type: Observational

To compare the effectiveness of autologous hematopoietic stem cell transplantation and chemotherapy as first-line consolidation therapy after obtaining a complete therapeutic response in T-cell lymphoma through a multicenter retrospective real-world study in China.

NCT ID: NCT03207789 Enrolling by invitation - T-cell Lymphoma Clinical Trials

T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients

Tcell-Brazil
Start date: January 1, 2015
Phase: N/A
Study type: Observational [Patient Registry]

The designed study follows up on the previous one by the international T-cell project (Bellei et al,, 2012) and its purpose is to verify whether a prospective collection of data would permit access to more accurate information permitting a better definition of prognosis and investigation of more adequate treatment strategies for these neoplasms. The analysis of patients distributed in all five macro regions of the country and a comparison among them will provide a real picture of the disease in Brazil, limiting the bias probably found in the previous projects.

NCT ID: NCT01788137 Recruiting - High Risk Clinical Trials

A Study of Improving the Efficacy of Treatment in High Risk T Cell Lymphoma Patients

Start date: January 2008
Phase: Phase 3
Study type: Interventional

This is a prospective , open, multicenter, randomized phase III study. The investigators planed to include 380 untreated high risk T cell lymphoma adults,to random to CHOP and c-ATT regimen groups after signature the informed consents. The patients will receive safety assessment every cycles, and efficacy evaluation every 3 cycles. Every-two-months follow up will be received after finishing the treatment.